Praxis assigns Kindler to Audit/Nominating, Arbuckle to Comp/Science & Tech; amends director comp policy

Praxis Precision Medicines, Inc.

Jeffrey B. Kindler appointed to Audit Committee and Nominating and Corporate Governance Committee effective Feb 6, 2026.
Stuart A. Arbuckle appointed to Compensation Committee and Science and Technology Committee effective Feb 6, 2026.
Board amended Non-Employee Director Compensation Policy; cash retainers: $50k board, $40k chair, plus committee chair/member fees.
New directors received initial RSUs ($220k) and pro-rata option/RSUs; annual awards: $110k option + $330k RSU for continuing directors.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.